Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 60,000 shares at $43.08 ($2.7M) on 2019-01-03, disclosed to the SEC on 2019-01-07.
Seasonal sale ($2.7M) by Chief Executive Officer — this insider has traded FGEN in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.08 | 11,900 | $513K | 19.2% |
| 2 | $44.12 | 11,493 | $507K | 19.0% |
| 3 | $44.84 | 6,507 | $292K | 11.0% |
| 4 | $45.75 | 100 | $5K | 0.2% |
| 5 | $44.12 | 4,400 | $194K | 7.3% |
| 6 | $45.05 | 25,600 |
| $1.2M |
| 43.3% |
| Total | $44.39 avg | 60,000 | $2.7M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |